← 홈

ADC · 림프종

170개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 170개
ADCBiologicEastern Cooperative Oncology Gr…Phase 2

DNA analysis (DNA analysis)

Lymphoma · Adult Lymphocyte Depletion Hodgkin Lymph

#AdultLymphocyteDepletionHodgkinL#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 18%임상시험 68상태 ACTIVE
ADCBiologicPETHEMA Foundationvedotin efficacy in DLBCL w…Approved

R-CHOP (R-CHOP)

HIV Infections; Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma (DLBCL)

#DiffuseLargeBCellLymphomaDLBCL#ADC#Approved#인기#항체약물접합체+5
효능 ORR 95%임상시험 66상태 RECRUITING
ADCBiologicEuropean Organisation for Resea…Phase 2

Ara C (Ara C)

Lymphoma; Leukemia · CLASSICAL HODGKIN LYMPHOMA

#CLASSICALHODGKINLYMPHOMA#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 45.2%임상시험 65상태 ACTIVE
ADCBiologicCelyad Oncology SAPhase 2

Endoxan (Endoxan)

Relapse/Refractory Multiple Myeloma · Lymphoma, T-Cell, Peripheral

#LymphomaT-CellPeripheral#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 62상태 ACTIVE
ADCBiologicARCAGYGovitecanPhase 2

GCSF (GCSF)

Ovarian Cancer · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 20.4%임상시험 62상태 DISCONTINUED
ADCBiologicCelgenevedotin (BV) maintenance th…Phase 3

High Dose Chemotherapy (High Dose Chemotherapy)

Recurrent Classic Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphoma · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 29%임상시험 62상태 RECRUITING
ADCBiologicThe Lymphoma Academic Research …vedotin plus doxorubicin [A…Phase 2

Oncovin (Oncovin)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 95%임상시험 62상태 ACTIVE
ADCBiologicBristol-Myers SquibbPhase 1

Revlimid (Revlimid)

Lymphoma; Non-Hodgkin Lymphoma · Lymphoma

#Lymphoma#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 90%임상시험 62상태 RECRUITING
ADCBiologicEnyo PharmaPhase 2

B-CAP (B-CAP)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 0.04%임상시험 61상태 ACTIVE
ADCBiologicNovumvedotin, nivolumab, doxorub…Phase 3

Bleomycin Sulfate (Bleomycin Sulfate)

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 · Lugano Classification Limited Stage Hodg

#LuganoClassificationLimitedStage#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 96%임상시험 61상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCvedotin with dacarbazine or…Phase 2

DTIC (DTIC)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 96%임상시험 61상태 RECRUITING
ADCBiologicRegeneron PharmaceuticalsPhase 3

Prednisone/ prednisolone (Prednisone/ prednisolone)

Follicular Lymphoma (FL) · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 95%임상시험 61상태 RECRUITING
ADCBiologicPfizerPhase 2

Sunitinib Malate (Sunitinib Malate)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 59%임상시험 61상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCsPhase 2

Hyaluronidase (Hyaluronidase)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 64.3%임상시험 59상태 DISCONTINUED
ADCBiologicGenzyme, a Sanofi Companyvedotin-based regimens in C…Phase 2

Reduced Intensity Conditioning (Reduced Intensity Conditioning)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 2%임상시험 59상태 ACTIVE
ADCBiologicJanssen Research & Development,…Phase 2

PEG asparaginase (PEG asparaginase)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · Leukemia

#Leukemia#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 14.3%임상시험 58상태 ACTIVE
ADCBiologicAmerican Society of Clinical On…Phase 2

Dabrafenib plus Trametinib (Dabrafenib plus Trametinib)

Lymphoma, Non-Hodgkin; Multiple Myeloma · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 57상태 RECRUITING
ADCBiologicSeagenvedotin-containing regimen …Phase 2

BV (BrentuximabVedotin, BrentuximabVedotin (BV))

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 2%임상시험 56상태 ACTIVE
ADCBiologicBeijing InnoCare Pharma Tech Co…Phase 3

Orelabrutinib (Orelabrutinib)

Primary Central Nervous System Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#ADC#Phase3#인기#항체약물접합체+3
임상시험 56상태 RECRUITING
ADCBiologicCelgeneVedotinPhase 1

Romidepsin (Romidepsin)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · Cutaneous T-cell Lymphoma (CTCL)

#CutaneousT-cellLymphomaCTCL#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 50%임상시험 53상태 ACTIVE

2 / 9 페이지

← 이전다음 →